Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 75 entries
Sorted by: Best Match Show Resources per page
C-Reactive Protein and Frailty in the Elderly: A Literature Review.

Journal of clinical medicine research

Velissaris D, Pantzaris N, Koniari I, Koutsogiannis N, Karamouzos V, Kotroni I, Skroumpelou A, Ellul J.
PMID: 28496545
J Clin Med Res. 2017 Jun;9(6):461-465. doi: 10.14740/jocmr2959w. Epub 2017 Apr 26.

Chronic inflammation is a well-established background process in many age-related diseases. Many recent studies investigate the use of various inflammatory biomarkers such as C-reactive protein (CRP), interleukin-6, and interleukin-1 as predictors of physical and cognitive performance among elders. The...

Cite
Velissaris D, Pantzaris N, Koniari I, et al. C-Reactive Protein and Frailty in the Elderly: A Literature Review. J Clin Med Res. 2017;9(6):461-465doi: 10.14740/jocmr2959w.
Velissaris, D., Pantzaris, N., Koniari, I., Koutsogiannis, N., Karamouzos, V., Kotroni, I., Skroumpelou, A., & Ellul, J. (2017). C-Reactive Protein and Frailty in the Elderly: A Literature Review. Journal of clinical medicine research, 9(6), 461-465. https://doi.org/10.14740/jocmr2959w
Velissaris, Dimitrios, et al. "C-Reactive Protein and Frailty in the Elderly: A Literature Review." Journal of clinical medicine research vol. 9,6 (2017): 461-465. doi: https://doi.org/10.14740/jocmr2959w
Velissaris D, Pantzaris N, Koniari I, Koutsogiannis N, Karamouzos V, Kotroni I, Skroumpelou A, Ellul J. C-Reactive Protein and Frailty in the Elderly: A Literature Review. J Clin Med Res. 2017 Jun;9(6):461-465. doi: 10.14740/jocmr2959w. Epub 2017 Apr 26. PMID: 28496545; PMCID: PMC5412518.
Copy Download .nbib Format: NLM
Alterations in Thyroid Hormones and Thyrotropin (TSH) in Morbidly Obese Patients before and after Vertical Gastroplasty.

Obesity surgery

Papavramidis ST, Zisiadis AC, Karamouzis MN, Kessissoglou II, Antoniadou HA, Aidonopoulos AP.
PMID: 10733815
Obes Surg. 1995 Aug;5(3):298-301. doi: 10.1381/096089295765557674.

BACKGROUND: Published results of studies of thyroid function in obesity and after weight loss have differed. METHODS: The circulating concentrations of thyroid hormones and TSH were studied in 30 consecutive, euthyroid morbidly obese patients before and after weight loss...

Cite
Papavramidis ST, Zisiadis AC, Karamouzis MN, et al. Alterations in Thyroid Hormones and Thyrotropin (TSH) in Morbidly Obese Patients before and after Vertical Gastroplasty. Obes Surg. 1995;5(3):298-301doi: 10.1381/096089295765557674.
Papavramidis, S. T., Zisiadis, A. C., Karamouzis, M. N., Kessissoglou, I. I., Antoniadou, H. A., & Aidonopoulos, A. P. (1995). Alterations in Thyroid Hormones and Thyrotropin (TSH) in Morbidly Obese Patients before and after Vertical Gastroplasty. Obesity surgery, 5(3), 298-301. https://doi.org/10.1381/096089295765557674
Papavramidis, et al. "Alterations in Thyroid Hormones and Thyrotropin (TSH) in Morbidly Obese Patients before and after Vertical Gastroplasty." Obesity surgery vol. 5,3 (1995): 298-301. doi: https://doi.org/10.1381/096089295765557674
Papavramidis ST, Zisiadis AC, Karamouzis MN, Kessissoglou II, Antoniadou HA, Aidonopoulos AP. Alterations in Thyroid Hormones and Thyrotropin (TSH) in Morbidly Obese Patients before and after Vertical Gastroplasty. Obes Surg. 1995 Aug;5(3):298-301. doi: 10.1381/096089295765557674. PMID: 10733815.
Copy Download .nbib Format: NLM
Season of birth, clinical manifestations and Dexamethasone Suppression Test in unipolar major depression.

Annals of general psychiatry

Fountoulakis KN, Iacovides A, Karamouzis M, Kaprinis GS, Ierodiakonou C.
PMID: 17683542
Ann Gen Psychiatry. 2007 Aug 03;6:20. doi: 10.1186/1744-859X-6-20.

BACKGROUND: Reports in the literature suggest that the season of birth might constitute a risk factor for the development of a major psychiatric disorder, possibly because of the effect environmental factors have during the second trimester of gestation. The...

Cite
Fountoulakis KN, Iacovides A, Karamouzis M, et al. Season of birth, clinical manifestations and Dexamethasone Suppression Test in unipolar major depression. Ann Gen Psychiatry. 2007;6:20doi: 10.1186/1744-859X-6-20.
Fountoulakis, K. N., Iacovides, A., Karamouzis, M., Kaprinis, G. S., & Ierodiakonou, C. (2007). Season of birth, clinical manifestations and Dexamethasone Suppression Test in unipolar major depression. Annals of general psychiatry, 620. https://doi.org/10.1186/1744-859X-6-20
Fountoulakis, Konstantinos N, et al. "Season of birth, clinical manifestations and Dexamethasone Suppression Test in unipolar major depression." Annals of general psychiatry vol. 6 (2007): 20. doi: https://doi.org/10.1186/1744-859X-6-20
Fountoulakis KN, Iacovides A, Karamouzis M, Kaprinis GS, Ierodiakonou C. Season of birth, clinical manifestations and Dexamethasone Suppression Test in unipolar major depression. Ann Gen Psychiatry. 2007 Aug 03;6:20. doi: 10.1186/1744-859X-6-20. PMID: 17683542; PMCID: PMC1965464.
Copy Download .nbib Format: NLM
Performance and cost comparison of a FWS and a VSF constructed wetland system.

Environmental technology

Tsihrintzis VA, Akratos CS, Gikas GD, Karamouzis D, Angelakis AN.
PMID: 17624102
Environ Technol. 2007 Jun;28(6):621-8. doi: 10.1080/09593332808618820.

Two constructed wetland systems, treating domestic wastewater, are compared in terms of performance and costs. One is a free water surface (FWS) wetland system located in Pompia, Crete, south Greece, and the other one is a vertical subsurface flow...

Cite
Tsihrintzis VA, Akratos CS, Gikas GD, et al. Performance and cost comparison of a FWS and a VSF constructed wetland system. Environ Technol. 2007;28(6):621-8doi: 10.1080/09593332808618820.
Tsihrintzis, V. A., Akratos, C. S., Gikas, G. D., Karamouzis, D., & Angelakis, A. N. (2007). Performance and cost comparison of a FWS and a VSF constructed wetland system. Environmental technology, 28(6), 621-8. https://doi.org/10.1080/09593332808618820
Tsihrintzis, V A, et al. "Performance and cost comparison of a FWS and a VSF constructed wetland system." Environmental technology vol. 28,6 (2007): 621-8. doi: https://doi.org/10.1080/09593332808618820
Tsihrintzis VA, Akratos CS, Gikas GD, Karamouzis D, Angelakis AN. Performance and cost comparison of a FWS and a VSF constructed wetland system. Environ Technol. 2007 Jun;28(6):621-8. doi: 10.1080/09593332808618820. PMID: 17624102.
Copy Download .nbib Format: NLM
Prolonged high-dose intravenous magnesium therapy for severe tetanus in the intensive care unit: a case series.

Journal of medical case reports

Karanikolas M, Velissaris D, Marangos M, Karamouzos V, Fligou F, Filos KS.
PMID: 20356376
J Med Case Rep. 2010 Mar 31;4:100. doi: 10.1186/1752-1947-4-100.

INTRODUCTION: Tetanus rarely occurs in developed countries, but it can result in fatal complications including respiratory failure due to generalized muscle spasms. Magnesium infusion has been used to treat spasticity in tetanus, and its effectiveness is supported by several...

Cite
Karanikolas M, Velissaris D, Marangos M, et al. Prolonged high-dose intravenous magnesium therapy for severe tetanus in the intensive care unit: a case series. J Med Case Rep. 2010;4:100doi: 10.1186/1752-1947-4-100.
Karanikolas, M., Velissaris, D., Marangos, M., Karamouzos, V., Fligou, F., & Filos, K. S. (2010). Prolonged high-dose intravenous magnesium therapy for severe tetanus in the intensive care unit: a case series. Journal of medical case reports, 4100. https://doi.org/10.1186/1752-1947-4-100
Karanikolas, Menelaos, et al. "Prolonged high-dose intravenous magnesium therapy for severe tetanus in the intensive care unit: a case series." Journal of medical case reports vol. 4 (2010): 100. doi: https://doi.org/10.1186/1752-1947-4-100
Karanikolas M, Velissaris D, Marangos M, Karamouzos V, Fligou F, Filos KS. Prolonged high-dose intravenous magnesium therapy for severe tetanus in the intensive care unit: a case series. J Med Case Rep. 2010 Mar 31;4:100. doi: 10.1186/1752-1947-4-100. PMID: 20356376; PMCID: PMC2862042.
Copy Download .nbib Format: NLM
Current advances of targeting HGF/c-Met pathway in gastric cancer.

Annals of translational medicine

Anestis A, Zoi I, Karamouzis MV.
PMID: 30069449
Ann Transl Med. 2018 Jun;6(12):247. doi: 10.21037/atm.2018.04.42.

Despite the advances in systemic chemotherapy, gastric adenocarcinoma (GC) remains the third most common cause of cancer-related deaths with poor prognosis. The heterogeneity of GC indicates that novel biomarkers should be established in order to further classify tumors and...

Cite
Anestis A, Zoi I, Karamouzis MV. Current advances of targeting HGF/c-Met pathway in gastric cancer. Ann Transl Med. 2018;6(12):247doi: 10.21037/atm.2018.04.42.
Anestis, A., Zoi, I., & Karamouzis, M. V. (2018). Current advances of targeting HGF/c-Met pathway in gastric cancer. Annals of translational medicine, 6(12), 247. https://doi.org/10.21037/atm.2018.04.42
Anestis, Aristomenis, et al. "Current advances of targeting HGF/c-Met pathway in gastric cancer." Annals of translational medicine vol. 6,12 (2018): 247. doi: https://doi.org/10.21037/atm.2018.04.42
Anestis A, Zoi I, Karamouzis MV. Current advances of targeting HGF/c-Met pathway in gastric cancer. Ann Transl Med. 2018 Jun;6(12):247. doi: 10.21037/atm.2018.04.42. PMID: 30069449; PMCID: PMC6046293.
Copy Download .nbib Format: NLM
Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.

Oncotarget

Mihailidou C, Papakotoulas P, Papavassiliou AG, Karamouzis MV.
PMID: 29535812
Oncotarget. 2017 Dec 08;9(12):10360-10374. doi: 10.18632/oncotarget.23164. eCollection 2018 Feb 13.

Ciclopirox olamine (CPX) is an antifungal agent that has recently demonstrated promising anti-neoplastic activity against hematologic and solid tumors. Here, we evaluated CPX compared with gemcitabine alone as well as their combination in human pancreatic cancer cell lines; BxPC-3,...

Cite
Mihailidou C, Papakotoulas P, Papavassiliou AG, et al. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Oncotarget. 2017;9(12):10360-10374doi: 10.18632/oncotarget.23164.
Mihailidou, C., Papakotoulas, P., Papavassiliou, A. G., & Karamouzis, M. V. (2018). Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Oncotarget, 9(12), 10360-10374. https://doi.org/10.18632/oncotarget.23164
Mihailidou, Chrysovalantou, et al. "Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models." Oncotarget vol. 9,12 (2018): 10360-10374. doi: https://doi.org/10.18632/oncotarget.23164
Mihailidou C, Papakotoulas P, Papavassiliou AG, Karamouzis MV. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Oncotarget. 2017 Dec 08;9(12):10360-10374. doi: 10.18632/oncotarget.23164. eCollection 2018 Feb 13. PMID: 29535812; PMCID: PMC5828195.
Copy Download .nbib Format: NLM
YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango.

Biomedicines

Matthaios D, Tolia M, Mauri D, Kamposioras K, Karamouzis M.
PMID: 34944765
Biomedicines. 2021 Dec 20;9(12). doi: 10.3390/biomedicines9121949.

Hippo pathway with its main molecule YAP is a crucial pathway for development, tissue homeostasis, wound healing, tissue regeneration, and cancer. In this review, we discuss the multiple effects of the YAP/Hippo pathway in the immune system and cancer....

Cite
Matthaios D, Tolia M, Mauri D, et al. YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango. Biomedicines. 2021;9(12)doi: 10.3390/biomedicines9121949.
Matthaios, D., Tolia, M., Mauri, D., Kamposioras, K., & Karamouzis, M. (2021). YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango. Biomedicines, 9(12), . https://doi.org/10.3390/biomedicines9121949
Matthaios, Dimitrios, et al. "YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango." Biomedicines vol. 9,12 (2021). doi: https://doi.org/10.3390/biomedicines9121949
Matthaios D, Tolia M, Mauri D, Kamposioras K, Karamouzis M. YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango. Biomedicines. 2021 Dec 20;9(12). doi: 10.3390/biomedicines9121949. PMID: 34944765; PMCID: PMC8698579.
Copy Download .nbib Format: NLM
YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango.

Biomedicines

Matthaios D, Tolia M, Mauri D, Kamposioras K, Karamouzis M.
PMID: 34944765
Biomedicines. 2021 Dec 20;9(12). doi: 10.3390/biomedicines9121949.

Hippo pathway with its main molecule YAP is a crucial pathway for development, tissue homeostasis, wound healing, tissue regeneration, and cancer. In this review, we discuss the multiple effects of the YAP/Hippo pathway in the immune system and cancer....

Cite
Matthaios D, Tolia M, Mauri D, et al. YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango. Biomedicines. 2021;9(12)doi: 10.3390/biomedicines9121949.
Matthaios, D., Tolia, M., Mauri, D., Kamposioras, K., & Karamouzis, M. (2021). YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango. Biomedicines, 9(12), . https://doi.org/10.3390/biomedicines9121949
Matthaios, Dimitrios, et al. "YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango." Biomedicines vol. 9,12 (2021). doi: https://doi.org/10.3390/biomedicines9121949
Matthaios D, Tolia M, Mauri D, Kamposioras K, Karamouzis M. YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango. Biomedicines. 2021 Dec 20;9(12). doi: 10.3390/biomedicines9121949. PMID: 34944765.
Copy Download .nbib Format: NLM
Cholangiocarcinoma: the role of genetic and epigenetic factors; current and prospective treatment with checkpoint inhibitors and immunotherapy.

American journal of translational research

Sarantis P, Tzanetatou ED, Ioakeimidou E, Vallilas C, Androutsakos T, Damaskos C, Garmpis N, Garmpi A, Papavassiliou AG, Karamouzis MV.
PMID: 35035673
Am J Transl Res. 2021 Dec 15;13(12):13246-13260. eCollection 2021.

Cholangiocarcinoma (CCA) represents 3% of all gastrointestinal cancers worldwide and is the second most common primary liver tumor after hepatocellular carcinoma. CCA is an aggressive tumor that involves the intrahepatic, perihilar and distal biliary tree, with a poor prognosis...

Cite
Sarantis P, Tzanetatou ED, Ioakeimidou E, et al. Cholangiocarcinoma: the role of genetic and epigenetic factors; current and prospective treatment with checkpoint inhibitors and immunotherapy. Am J Transl Res. 2021;13(12):13246-13260
Sarantis, P., Tzanetatou, E. D., Ioakeimidou, E., Vallilas, C., Androutsakos, T., Damaskos, C., Garmpis, N., Garmpi, A., Papavassiliou, A. G., & Karamouzis, M. V. (2021). Cholangiocarcinoma: the role of genetic and epigenetic factors; current and prospective treatment with checkpoint inhibitors and immunotherapy. American journal of translational research, 13(12), 13246-13260.
Sarantis, Panagiotis, et al. "Cholangiocarcinoma: the role of genetic and epigenetic factors; current and prospective treatment with checkpoint inhibitors and immunotherapy." American journal of translational research vol. 13,12 (2021): 13246-13260.
Sarantis P, Tzanetatou ED, Ioakeimidou E, Vallilas C, Androutsakos T, Damaskos C, Garmpis N, Garmpi A, Papavassiliou AG, Karamouzis MV. Cholangiocarcinoma: the role of genetic and epigenetic factors; current and prospective treatment with checkpoint inhibitors and immunotherapy. Am J Transl Res. 2021 Dec 15;13(12):13246-13260. eCollection 2021. PMID: 35035673; PMCID: PMC8748131.
Copy Download .nbib Format: NLM
The Implication of Autophagy in Gastric Cancer Progression.

Life (Basel, Switzerland)

Koustas E, Trifylli EM, Sarantis P, Kontolatis NI, Damaskos C, Garmpis N, Vallilas C, Garmpi A, Papavassiliou AG, Karamouzis MV.
PMID: 34947835
Life (Basel). 2021 Nov 27;11(12). doi: 10.3390/life11121304.

Gastric cancer is the fifth most common malignancy and the third leading cause of cancer-related death worldwide. The three entirely variable entities have distinct epidemiology, molecular characteristics, prognosis, and strategies for clinical management. However, many gastric tumors appear to...

Cite
Koustas E, Trifylli EM, Sarantis P, et al. The Implication of Autophagy in Gastric Cancer Progression. Life (Basel). 2021;11(12)doi: 10.3390/life11121304.
Koustas, E., Trifylli, E. M., Sarantis, P., Kontolatis, N. I., Damaskos, C., Garmpis, N., Vallilas, C., Garmpi, A., Papavassiliou, A. G., & Karamouzis, M. V. (2021). The Implication of Autophagy in Gastric Cancer Progression. Life (Basel, Switzerland), 11(12), . https://doi.org/10.3390/life11121304
Koustas, Evangelos, et al. "The Implication of Autophagy in Gastric Cancer Progression." Life (Basel, Switzerland) vol. 11,12 (2021). doi: https://doi.org/10.3390/life11121304
Koustas E, Trifylli EM, Sarantis P, Kontolatis NI, Damaskos C, Garmpis N, Vallilas C, Garmpi A, Papavassiliou AG, Karamouzis MV. The Implication of Autophagy in Gastric Cancer Progression. Life (Basel). 2021 Nov 27;11(12). doi: 10.3390/life11121304. PMID: 34947835.
Copy Download .nbib Format: NLM
Neutrophil-to-lymphocyte Ratio Relation to Sepsis Severity Scores and Inflammatory Biomarkers in Patients with Community-acquired Pneumonia: A Case Series.

Journal of translational internal medicine

Pantzaris ND, Platanaki C, Pierrako C, Karamouzos V, Velissaris D.
PMID: 29607304
J Transl Int Med. 2018 Mar 28;6(1):43-46. doi: 10.2478/jtim-2018-0009. eCollection 2018 Mar.

BACKGROUND AND OBJECTIVES: Neutrophil to lymphocyte ratio (NLR) as calculated from the white cell differential blood count is considered a promising marker for the prognosis of patients with various diseases, including sepsis. This study was designed to assess the...

Cite
Pantzaris ND, Platanaki C, Pierrako C, et al. Neutrophil-to-lymphocyte Ratio Relation to Sepsis Severity Scores and Inflammatory Biomarkers in Patients with Community-acquired Pneumonia: A Case Series. J Transl Int Med. 2018;6(1):43-46doi: 10.2478/jtim-2018-0009.
Pantzaris, N. D., Platanaki, C., Pierrako, C., Karamouzos, V., & Velissaris, D. (2018). Neutrophil-to-lymphocyte Ratio Relation to Sepsis Severity Scores and Inflammatory Biomarkers in Patients with Community-acquired Pneumonia: A Case Series. Journal of translational internal medicine, 6(1), 43-46. https://doi.org/10.2478/jtim-2018-0009
Pantzaris, Nikolaos-Dimitrios, et al. "Neutrophil-to-lymphocyte Ratio Relation to Sepsis Severity Scores and Inflammatory Biomarkers in Patients with Community-acquired Pneumonia: A Case Series." Journal of translational internal medicine vol. 6,1 (2018): 43-46. doi: https://doi.org/10.2478/jtim-2018-0009
Pantzaris ND, Platanaki C, Pierrako C, Karamouzos V, Velissaris D. Neutrophil-to-lymphocyte Ratio Relation to Sepsis Severity Scores and Inflammatory Biomarkers in Patients with Community-acquired Pneumonia: A Case Series. J Transl Int Med. 2018 Mar 28;6(1):43-46. doi: 10.2478/jtim-2018-0009. eCollection 2018 Mar. PMID: 29607304; PMCID: PMC5874487.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 75 entries